You are here

GSK

GSK scratches itch for phase 3 win, hitting goal in liver disease trial to open up untapped market

Fierce Biotech

Tue, 11/19/24 - 11:18 am

clinical trials

GSK hails survival data with revived myeloma drug Blenrep

Pharmaphorum

Thu, 11/14/24 - 10:03 am

Multiple Myeloma

clinical trials

GSK launches gynecological cancer initiative after survey reveals care gaps

Medical Marketing and Media

Tue, 11/12/24 - 08:46 pm

gynecological cancers

GSK partners with Flagship startup to hunt for Parkinson’s drugs

BioPharma Dive

Tue, 11/12/24 - 08:43 pm

Vesalius Therapeutics

Parkinson's Disease

GSK calls it quits on trade group BIO for 2025, following exits by Takeda, UCB and more

Fierce Pharma

Sun, 11/10/24 - 09:33 pm

GSK CEO addresses declining trust in vaccines following Trump re-election

Clinical Trials Arena

Thu, 11/7/24 - 11:26 am

GSK’s RSV vaccine approved in Canada for adults aged 50 to 59

Pharmaceutical Technology

Wed, 11/6/24 - 08:04 pm

GSK axes vaccine from $2.1B deal, switching to preclinical successor over 'increased competition'

Fierce Biotech

Thu, 10/31/24 - 09:37 am

pneumococcal disease

GSK tries to steady the ship as Arexvy sales plummet in wake of CDC guidance changes

Fierce Pharma

Wed, 10/30/24 - 11:47 am

GSK to pay $300M to license drug it sees as potential lupus treatment

BioPharma Dive

Tue, 10/29/24 - 11:38 am

GSK plans $800m US manufacturing investment

Pharmaphorum

Fri, 10/25/24 - 11:05 am

drug manufacturing

GSK answers Pfizer's RSV approval with data targeting matching nod in younger adults

Fierce Pharma

Thu, 10/24/24 - 10:58 am

Cambridge and GSK announce new five-year collaboration aiming for improved outcomes for patients with hard-to-treat kidney and respiratory diseases

Cambridge University

Mon, 10/21/24 - 11:05 am

Cambridge University

respiratory disease

With Gilead coming fast, GSK bolsters case for long-acting HIV PrEP drug Apretude

Fierce Pharma

Thu, 10/17/24 - 09:23 am

Gilead Sciences

GSK takes mRNA patent fight to Moderna, suing over vaccines for COVID and RSV

Fierce Pharma

Wed, 10/16/24 - 10:02 am

Moderna Therapeutics

FDA set to decide on GSK's gepotidacin antibiotic in March

Pharmaphorum

Wed, 10/16/24 - 09:56 am

GSK asthma hope depemokimab works in second indication

Pharmaphorum

Mon, 10/14/24 - 10:01 am

clinical trials

chronic rhinosinusitis with nasal polyps

GSK will pony up $2.2B to resolve 80K Zantac cases

Fierce Pharma

Wed, 10/9/24 - 09:10 pm

GSK says RSV vaccine protects against disease over three seasons

BioPharma Dive

Tue, 10/8/24 - 09:47 pm

clinical trials

GSK, Pfizer RSV vaccine sales fall in US as millions fewer people line up

Reuters

Tue, 10/8/24 - 11:17 am

Pages